Party is over......

Quote












Anonymous said:
You are a complete fool if you don't think our sales force will be cut! Bank on it!
Click to expand...

We get it, you fucking idiot. If the sales force is cut, it is. We don't need you coming on here talking shit like you're some sort of all-knowing prophet. I can't control it, and I doubt you can either. I also doubt you have any sort of concrete information. Rumors maybe. Obvious troll is trolling again.
 


















Anonymous said:
Yeah, you wish. Pilo's destruction commercial accounts (United, CVS, Wellpoint) AND his running off govt MC talent is the BIGGEST reason you are losing ground, market share has dropped - he is singularly responsible for this huge loss of business. The buffoon still thinks he's all that.

And PS. the former govt MC managers had valuable skills in dealing with P&Ts and working relationships with key people. The only people left are former CLs who have no business managing payer accounts. Sad.
Click to expand...

Biggest reason we are losing share and market is decreasing in value is due to all the generics in the market. My local CVS pushes generics first line because of price. No one cares about gov't due to low cost margins it is all about cash paying commercial customers. We all get the memos. Now stop whining and sell.
 






FDA approves two higher dosage strengths of Orexo's ZUBSOLV

The new dosage strengths are 8.6 mg/2.1 mg and 11.4 mg/2.9 mg buprenorphine/naloxone CIII sublingual tablets. The 8.6 mg/2.1 mg dosage strength is expected to be launched early 2015 and the 11.4 mg/2.9 mg strength later in 2015.

The new dosage strengths complement the existing strengths of 5.7 mg/1.4 mg and 1.4 mg/0.36 mg tablets and enable patients to receive their optimal dose in one tablet.

The new strengths are made with the advanced, proprietary sublingual tablet formulation in ZUBSOLV providing higher bioavailability, a fast dissolve time, small tablet size, and menthol flavor
 






Philipi said:
FDA approves two higher dosage strengths of Orexo's ZUBSOLV

The new dosage strengths are 8.6 mg/2.1 mg and 11.4 mg/2.9 mg buprenorphine/naloxone CIII sublingual tablets. The 8.6 mg/2.1 mg dosage strength is expected to be launched early 2015 and the 11.4 mg/2.9 mg strength later in 2015.

The new dosage strengths complement the existing strengths of 5.7 mg/1.4 mg and 1.4 mg/0.36 mg tablets and enable patients to receive their optimal dose in one tablet.

The new strengths are made with the advanced, proprietary sublingual tablet formulation in ZUBSOLV providing higher bioavailability, a fast dissolve time, small tablet size, and menthol flavor
Click to expand...

Old news. Already got the memo and message.
 






The Party is not necessarily over, the market and competitive landscape however have changed. Its about time the whining counselors and wanna be sales people go and get a job where they don't have to ask for or earn the business. For years the Cl's showed up in offices and basically did nothing. So now we have a managed care team that basically does nothing except loose business and a CL team that does not know how to keep it. Pathetic.
 






Anonymous said:
The Party is not necessarily over, the market and competitive landscape however have changed. Its about time the whining counselors and wanna be sales people go and get a job where they don't have to ask for or earn the business. For years the Cl's showed up in offices and basically did nothing. So now we have a managed care team that basically does nothing except loose business and a CL team that does not know how to keep it. Pathetic.
Click to expand...

THIS IS THE WHOLE REALITY IN A NUTSHELL!!! BRAVO!!!

TAKE THAT...."PIONEERS" LOL!!!!
 










































Shit J, still the spelling police eh? Damn, some things never change. If you spent half as much time fixing your f ups, as you do others, you might make some headway. That would be to much for you though. Nah, it's far more easy & fun pointing out other's mistakes. That's been your speed all along.
 






Anonymous said:
2 things.

-It's "lose". Not "loose". How can you not know the difference?
-When you get a Managed Care win or equal footing, do you give them credit?
Click to expand...

I think a lot of people gave credit to the mc team.....but we were the only one on the market. So one could look at the present time and say the mc team is Junior Varsity because they just seem not to compete with the other brands to mc companies. I mean we have 2 other brands and somehow we fall short. So yes when we were competing against OURSELVES the mc team was great but when we hit the actual game you kind of SUCK.
 












Anonymous said:
I think a lot of people gave credit to the mc team.....but we were the only one on the market. So one could look at the present time and say the mc team is Junior Varsity because they just seem not to compete with the other brands to mc companies. I mean we have 2 other brands and somehow we fall short. So yes when we were competing against OURSELVES the mc team was great but when we hit the actual game you kind of SUCK.
Click to expand...

Still having a hard time figuring out how a start up company like Orexo with a handful of employees kick our ass in managed care so quickly?? Its a shame given our ten year period of exclusivity and billions of dollars in sales, we could not defend our positions. I'm spending most of my time with Drs explaining managed care formularies and how to get Suboxone approved.
 






Top Bottom
Back
Quote